Baird analyst Catherine Ramsey Schulte lowered the firm’s price target on Thermo Fisher to $625 from $664 and keeps an Outperform rating on the shares. The firm noted they reported 2Q results below the Street and lowered guidance on China weakness, bioproduction softness, and a deteriorating macro environment more broadly increasing customer caution.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TMO:
- Thermo Fisher price target raised to $625 from $590 at Barclays
- Thermo Fisher Scientific Earnings Report: Did it Beat Expectations?
- Thermo Fisher says macro environment has become more challenged
- Thermo Fisher (NYSE:TMO) Cools Down on Big Q2 Miss
- Thermo Fisher cuts FY23 adjusted EPS view to $22.28-$22.72 from $23.70